Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|January 1, 1996
Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelinesS C Piscitelli, M A Amatea, S Vogel, et al.Pharmacotherapy|September 1, 1996
Pharmacokinetics and pharmacodynamics of subcutaneous interleukin-2 in HIV-infected patientsS C Piscitelli, M J Wells, J A Metcalf, et al.Pharmacotherapy|May 1, 1997
Pharmacometric analysis of the effect of furosemide on suramin pharmacokineticsS C Piscitelli, A Forrest, R M Lush, et al.Antimicrobial Agents and Chemotherapy|July 18, 2000
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokineticsM K Jordan, M A Polis, G Kelly, et al.The Annals of Pharmacotherapy|December 1, 1993
Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinicS C Piscitelli, D J Occhipinti, L H Danziger, et al.Antimicrobial Agents and Chemotherapy|September 1, 1991
Effects of ranitidine and sucralfate on ketoconazole bioavailabilityS C Piscitelli, T F Goss, J H Wilton, et al.International Journal of Dermatology|March 1, 1993
Effectiveness of a dapsone compliance program in leprosyS C Piscitelli, L H Danziger, C Hill, et al.Antimicrobial Agents and Chemotherapy|February 13, 2001
Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbitsA H Groll, B M Gullick, R Petraitiene, et al.Cancer|August 1, 1994
The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancerD A Rushing, S R Raber, K A Rodvold, et al.Pharmacotherapy|December 17, 1998
Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virusS C Piscitelli, S Vogel, W D Figg, et al.Pageof 8